Enoblituzumab Biosimilar - Anti-CD276 Antibody - BSA and Azide free
Descrizione
Recombinant humanized monoclonal antibody to CD276.
Applicazioni
ELISA, Flow Cytometry
Diluizioni consigliate
Flow Cytometry: 1:100
Reattività
Human
Specie ospite
Humanized
Clonalità
Monoclonal
Isotipo
IgG1
Coniugare
Unconjugated
Purificazione
Affinity chromatography.
Concentrazione
Reconstitution dependent.
Forma del prodotto
Lyophilized
Ricostituzione
Reconstitute with distilled sterile water.
Formulazione
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Note generali
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
ELISA plate pre-coated by 2 µg/ml (100 µl/well) Recombinant Human CD276 Protein (Fc Chimera 6xHis Tag) (A318396) can bind Anti-CD276 Humanized Antibody [Enoblituzumab Biosimilar] - Azide free (A318946) in a linear range of 0.24-31.25 µg/ml.
HEK293 cell line transfected with irrelevant protein (B) and human B7-H3 (A) were surface stained with Anti-CD276 Humanized Antibody [Enoblituzumab Biosimilar] - Azide free (A318946) at 1 µg/ml followed by Anti-Human IgG Antibody (Alexa 488).
Prodotti alternativi a Anti-CD276 Anticorpo (A318946)